Literature DB >> 7010113

Immunity to Candida albicans.

T J Rogers, E Balish.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7010113      PMCID: PMC373198          DOI: 10.1128/mr.44.4.660-682.1980

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


× No keyword cloud information.
  193 in total

1.  Complications of Candida albicans infection in infancy.

Authors:  J M WAGNER; I KESSEL
Journal:  Br Med J       Date:  1958-08-09

2.  Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse.

Authors:  R P Hummel; E J Oestreicher; M P Maley; B G Macmillan
Journal:  J Surg Res       Date:  1973-07       Impact factor: 2.192

3.  Chronic mucocutaneous candidiasis: T cell deficiency associated with B cell dysfunction in man.

Authors:  L T Cahill; E Ainbender; P R Glade
Journal:  Cell Immunol       Date:  1974-11       Impact factor: 4.868

4.  Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.

Authors:  M L Schulking; W H Adler; W A Altemeier; E M Ayoub
Journal:  Cell Immunol       Date:  1972-04       Impact factor: 4.868

5.  Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis.

Authors:  T T Provost; L K Garrettson; R H Zeschke; N R Rose; T B Tomasi
Journal:  Clin Immunol Immunopathol       Date:  1973-07

6.  Letter: Beclomethasone aerosol in chronic bronchial asthma.

Authors:  I W Grant; G K Crompton; L J Milne
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

7.  Passive immunization of mice against Candida albicans.

Authors:  S Mourad; L Friedman
Journal:  Sabouraudia       Date:  1968-02

8.  Study of possible mechanisms of basophil accumulation in experimental cutaneous candidiasis in guinea pigs.

Authors:  P G Sohnle; C H Kirkpatrick
Journal:  J Allergy Clin Immunol       Date:  1977-02       Impact factor: 10.793

9.  Suppressor thymus-derived lymphocytes in fungal infection.

Authors:  J D Stobo; S Paul; R E Van Scoy; P E Hermans
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

10.  Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages.

Authors:  E M Peterson; R A Calderone
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

View more
  43 in total

1.  Purification, crystallization and preliminary X-ray diffraction studies of UDP-N-acetylglucosamine pyrophosphorylase from Candida albicans.

Authors:  Daisuke Maruyama; Yuichi Nishitani; Tsuyoshi Nonaka; Akiko Kita; Takaaki A Fukami; Toshiyuki Mio; Hisafumi Yamada-Okabe; Toshiko Yamada-Okabe; Kunio Miki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-04

2.  Rapid identification of Candida species in oral rinse solutions by PCR.

Authors:  Giorgio Liguori; Angela Lucariello; Giuseppe Colella; Antonio De Luca; Paolo Marinelli
Journal:  J Clin Pathol       Date:  2007-09       Impact factor: 3.411

Review 3.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

4.  CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; K Onogi; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 5.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Non-invasive imaging of disseminated candidiasis in zebrafish larvae.

Authors:  Kimberly M Brothers; Robert T Wheeler
Journal:  J Vis Exp       Date:  2012-07-30       Impact factor: 1.355

Review 7.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

8.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Induction of the immune response suppression in mice inoculated with Candida albicans.

Authors:  J C Valdez; D E Mesón; A Sirena; S F de Petrino; M Eugenia; B B de Jorrat; M G de Valdex
Journal:  Mycopathologia       Date:  1986-03       Impact factor: 2.574

10.  Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans.

Authors:  E Blasi; R Mazzolla; L Pitzurra; R Barluzzi; F Bistoni
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.